Zana is a deep tech healthcare company based in Germany, founded in 2018. The company leverages the power of voice and AI to support better health outcomes, offering solutions ranging from digital health companions to advanced voice-based diagnostics. Zana focuses on using digital voice biomarkers as quantifiable features that provide valuable insights into physical and mental well-being, particularly in respiratory diseases and cardiology, the leading causes of hospitalization worldwide.

Zana aims to revolutionize healthcare by employing AI-powered voice technology that enables proactive care, efficient remote monitoring, and prevention of hospitalization. Their AI platform analyzes voice patterns to detect potential health indicators and generate predictive health scores, integrating results seamlessly into preferred systems or via an API. The company is committed to ethical AI use and strives to drive positive societal impact through innovative technology.

Zana was founded by Dr.-Ing. Julia Hoxha (Co-Founder & CEO) and Dr. Armand Brahaj (Co-Founder & CTO), both experienced entrepreneurs with scientific backgrounds. The company has an international team with expertise in technology development, R&D, business development, and regulatory compliance.

Zana leads studies such as the Acute Heart Failure (AHF)-Voice Study at University Clinic Würzburg and collaborates with various clinical and industry partners, including Maastricht University Medical Center+. The company has received several awards and recognitions and holds a Medical Device CE Mark for their AI-driven health monitoring platform.

Zana is headquartered in Karlsruhe, Germany, with an office in Berlin. They encourage connection via their LinkedIn page and email contact at [email protected].